Daniel J. DeAngelo, MD, PhD¹, Andre C. Schuh, MD, FRCPC², Brian A. Jonas, MD, PhD³, Pamela S. Becker, MD, PhD⁴, Anjali S. Advani, MD⁵, Geoffrey L. Uy, MD⁶, Janusz Krawczyk, MD⁷, Harry P. Erba, MD, PhD⁸, Gabriel N Mannis, MD⁹, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD^10*, Florian Kuchenbauer, MD, PhD, FRCPC¹¹, Mary-Elizabeth M. Percival, MD¹², Jane L. Liesveld, MD¹³, William Blum, MD¹⁴, Brenda W Cooper, MD¹⁵, Alice Mims, MD¹⁶, Francesco Lanza, MD^17,18*, Jeroen J.W.M. Janssen¹⁹, Juan Miguel Bergua Burgues, MD^20*, Tibor Kovacsovics, MD^21*, Norbert Vey, MD²², Martina V. Hemmer, MA^23*, Gaetano Bonifacio, MD^23*, Edwin Rock, MD, PhD²³ and Pau Montesinos, PhD, MD^24*

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Medical Oncology and Hematology, University Health Network- University of toronto, Toronto, ON, Canada
³UC Davis Comprehensive Cancer Center, Davis, CA
⁴Hematology/HCT, City of Hope, Duarte, CA
⁵Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁶Washington University School of Medicine, Saint Louis
⁷Department of Haematology, University Hospital Galway, H91 Galway, Ireland; National University of Ireland, H91, Galway, Ireland
⁸Duke University Cancer Institute, Durham, NC
⁹Stanford, Stanford Cancer Center, Menlo Park, CA
¹⁰Department of Hematology, Austin Health, Heidelberg, VIC, Australia
¹¹Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, Canada
¹²Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
¹³Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
¹⁴Emory University, Winship Cancer Institute, Atlanta, GA
¹⁵Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
¹⁶The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁷Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy
¹⁸Hematology Unit and Metropolitan Romagna Transplant Network, University of Bologna, Ravenna, Italy
¹⁹Department of Hematology, Amsterdam University Medical Centers, VUmc, Amsterdam, Netherlands
²⁰Hospital San Pedro de Alcántara, Caceres, Spain
²¹City of Hope Phoenix, Goodyear, AZ
²²Paoli-Calmette Cancer Institute, Marseille, France
²³GlycoMimetics, Inc., Rockville, MD
²⁴Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain

Ian M. Bouligny, MD¹, Hagop M. Kantarjian, MD¹, Musa Yilmaz, MD¹, Naval Daver, MD², Gautam Borthakur, MD³, Courtney D. DiNardo, MD, MSc¹, Guillermo Montalban-Bravo, MD¹, Nicholas J. Short, MD¹, Yesid Alvarado Valero, MD¹, Elias Jabbour, MD¹, Nitin Jain, MD¹, Naveen Pemmaraju, MD⁴, Danielle Hammond, MD¹, Kelly S. Chien, MD⁵, Koichi Takahashi, MD, PhD⁶, Ghayas C. Issa, MD¹, Hussein A. Abbas, MD, PhD¹, Guillermo Garcia-Manero, MD¹, Farhad Ravandi, MBBS⁷ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²MD Anderson Cancer Center, Houston, TX
³Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
⁵Department of Leukemia, MD Anderson, Houston, TX
⁶Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Sankalp Arora, MBBS¹, Jayastu Senapati, MD, DM, MBBS², Sanam Loghavi, MD³, Patrick K. Reville, MD, MPH², Bofei Wang, PhD⁴, Tapan M. Kadia, MD², Courtney D. DiNardo, MD, MSc⁵, Naveen Pemmaraju, MD⁶, Musa Yilmaz, MD², Joseph E. Jabbour^7*, Nicholas J. Short, MD², Guillermo Montalban-Bravo, MD², Abhishek Maiti, MBBS², Guilin Tang, MD, PhD^3*, Koji Sasaki, MD², Gautam Borthakur, MD⁸, Joie Alvarez, BSN^9*, Sherry Pierce, BSN, BA^2*, Graciela M. Nogueras González^9*, Jing Ning, PhD^10*, Ghayas C. Issa, MD², Michael Andreeff, MD, PhD⁸, Farhad Ravandi, MBBS¹¹, Guillermo Garcia-Manero, MD², Hussein A. Abbas, MD, PhD² and Naval Daver, MD¹²

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, Division of Cancer Medicine, The University of Texas At MD Anderson Cancer Cent, Houston, TX
⁵Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
¹²MD Anderson Cancer Center, Houston, TX

Jessica M. Stempel, MD¹, Geoffrey L. Uy, MD², Shira N. Dinner, MD³, Ivana Gojo, MD⁴, Daniel R Reed, MD^5,6, Rupali Roy, MD^6*, Kenneth P Byrd, DO⁷, Swaroopa Yerrabothala, MD⁸, Catherine E. Lai, MD^9,10, Kimberley Doucette, MD¹⁰, Anne Caldwell, RN^1*, Ondrej Blaha, PhD^1,11*, Nikolai A. Podoltsev, MD, PhD¹, Lourdes M Mendez, MD, PhD^1*, Jan Philipp Bewersdorf, MD¹, Tariq Kewan, MD¹, Ignacio Wistuba, MD^12*, Gheath Alatrash, PhD, DO¹³, Cara L Haymaker, PhD^14*, Howard Streicher, MD^15*, Elad Sharon, MD, MPH^16*, Richard F. Little, MD, MPH¹⁵, Steven D. Gore, MD¹⁵, Jerald P. Radich, MD¹⁷, Brent L. Wood, MD, PhD¹⁸, Amer M. Zeidan, MBBS, MHS¹ and Rory M. Shallis, MD¹

¹Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
²Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
³Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁴Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁵Department of Medicine, Division of Hematology and Oncology, University of Virginia Medical Center Comprehensive Cancer Center, Charlottesville, VA
⁶Section on Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem, NC
⁷Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Leawood, KS
⁸Dartmouth Hitchcock Medical Center, Lebanon, NH
⁹Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁰Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
¹¹School of Public Health, Department of Biostatistics, Yale University, New Haven
¹²Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston
¹⁴Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
¹⁶Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁷Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Rsch. Ctr., Seattle, WA
¹⁸Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA

Eric S. Winer, MD¹, David Sallman, MD², Adolfo De la Fuente Burguera, MD^3*, Amit Verma, MBBS^4*, Katharina Goetze, MD^5*, Yasmin Abaza, MD⁶, James P. Dugan, MD⁷, Thomas Cluzeau, MD, PhD^8*, Eduardo Rodriguez Arboli, MD MPhil^9*, Alice Mims, MD¹⁰, Stefanie Groepper, MD^11*, Itay Zilbershatz, MD^12*, Jane L. Liesveld, MD¹³, Walter Fiedler, MD¹⁴, Stefano R Tarantolo, MD¹⁵, Lionel Ades, MD, PhD¹⁶, Nikolaos Papadantonakis, MD^17*, Christoph Schliemann, MD^18*, Gaurav S Choudhary, PhD^19*, Maureen Lane, PhD^19*, Wanying Zhao, PhD^19*, Ashish Jain, MS^19*, Cole Gallagher, BS^19* and Guillermo Garcia-Manero, MD²⁰

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³MD Anderson Cancer Center, Madrid, ESP
⁴Albert Einstein College of Medicine, Bronx, NY
⁵Clinic and Polyclinic for Internal Medicine III, Klinikum rechts der Isar, Muenchen, DEU
⁶Northwestern University, Chicago, IL
⁷Malignant Hematology and Cellular Therapy Department, Novant Health Cancer Institute - Forsyth Medical Center, Winston, Salem, NC
⁸Centre Hospitalier Universitaire de Nice, Nice, France
⁹Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), University of Seville, Sevilla, Spain
¹⁰Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹¹Marien Hospital, University of Düsseldorf, Düsseldorf, Germany
¹²The Edith Wolfson Health Center, Holon, Israel
¹³Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
¹⁴Department of Medicine II, University Hospital Eppendorf, Hamburg, Germany
¹⁵Nebraska Cancer Specialists, Omaha, NE
¹⁶Hopital Saint Louis, Paris, France
¹⁷Winship Cancer Institute of Emory University, Atlanta, GA
¹⁸Department of Medicine A, University Hospital Muenster, Muenster, Germany
¹⁹Curis Inc., Lexington, MA
²⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Pau Montesinos, PhD, MD^1*, Montserrat Arnan, MD, PhD^2*, Stephane De Botton^3*, Maria Calbacho, MD^4*, Rebeca Rodriguez Veiga, MD, PhD^5*, Pierre Bories, MD^6*, Belén Ansoleaga, MD, PhD^7*, Thomas Hueso, MD, PhD^8*, Naval Daver, MD⁹, Lydia Wunderle, MD^10*, Andreas Harstrick, MD^10*, Kerstin Pietzko^10*, Pallavi Hajela^10*, Alexandra Vasile, PhD^11*, Tania Witte, PhD^12*, Elmarie Saenger^10* and Christian Récher, MD^13*

¹Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain
²Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain
³Department of Hematology, Institut Gustave Roussy, Villejuif Cedex, France
⁴Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain
⁵Hospital Universitary i Politecnic La Fe, Valencia, ESP
⁶CHU de Toulouse-Institut Universitaire du Cancer Toulouse de Toulouse Oncopole, Toulouse, France
⁷Institut Català d’Oncologia-Hospital Duran i Reynals, Institut d’Investigacio Biomèdica de Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain
⁸Institut Gustave Roussy, Villejuif Cedex, France
⁹University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Affimed GmbH, Mannheim, Germany
¹¹Affimed GmBH, mannheim, Germany
¹²Affimed GmbH, Manheim, Germany
¹³IUCT-Oncopole, Hematology Department, CHU Toulouse, Toulouse, France